Buy SBI Life; target of Rs 2150: Emkay Global Financial

What happened

Emkay Global kept a BUY rating on SBI Life with a target of Rs 2,150, citing second-quarter VNB margins of 29.2% that beat its 27.2% estimate despite a GST input tax credit loss, helped by product mix changes.

Confirmed

Global impact / market context

Higher profit per policy sold, called VNB margin, means SBI Life keeps more value from each sale, supporting future earnings. Emkay sees 32% upside to its target, so investors are paid to own the stock if growth guidance holds.

Analyst inference

SBI Life's sales through the SBI and agency channels were soft, but management still guides 14-15% retail APE growth and 26-28% margins. Emkay calls it the best-placed insurer to grow profitably as regulation changes.

Analyst inference

What to watch

1. Emkay expects retail APE growth of about 14-15% and VNB margins of about 26-28% in FY27, so watch whether actual results land inside that guided range. Confirmed
2. Track whether the SBI and agency channels recover, since weak sales there held back APE growth, while non-par savings, annuity and term products drove the margin beat. Proposed
3. Watch whether the GST input tax credit loss keeps hurting costs, because margin gains came from product mix rather than that tax change, which affects cash costs. Analyst inference

Evidence

• Original source link unavailable